CryoPort Inc (CYRX)

[H2R]

Impact of CTL-019 on CYRX could be positive

[Edit: Should have been in response to Laser's 10484].

See SoS's new blurb on the subject: https://smithonstocks.com/fda-announces-july-12-adcom-meeting-for-ctl-019-thoughts-on-how-this-might-affect-investor-perceptions-of-kite-kite-underperform-80-25-and-cryoport-cyrx-buy-3-89/

CYRX would very likely benefit from Novartis approval

The FDA has announced that there will be an AdCom meeting for Novartis’ CTL-019 for the treatment of pediatric r/r ALL on July 12.

The FDA looks like they want to move on CAR-T...

Could be interesting :)